211 related articles for article (PubMed ID: 16546598)
1. Two randomized, double-blind, placebo-controlled studies of fluticasone propionate lotion 0.05% for the treatment of atopic dermatitis in subjects from 3 months of age.
Eichenfield LF; Miller BH;
J Am Acad Dermatol; 2006 Apr; 54(4):715-7. PubMed ID: 16546598
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of fluticasone propionate 0.005% ointment in the long-term maintenance treatment of children with atopic dermatitis: differences between boys and girls?
Glazenburg EJ; Wolkerstorfer A; Gerretsen AL; Mulder PG; Oranje AP
Pediatr Allergy Immunol; 2009 Feb; 20(1):59-66. PubMed ID: 18298423
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment.
Doss N; Kamoun MR; Dubertret L; Cambazard F; Remitz A; Lahfa M; de Prost Y
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):321-9. PubMed ID: 19563466
[TBL] [Abstract][Full Text] [Related]
5. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis.
Rosenblut A; Bardin PG; Muller B; Faris MA; Wu WW; Caldwell MF; Fokkens WJ
Allergy; 2007 Sep; 62(9):1071-7. PubMed ID: 17686110
[TBL] [Abstract][Full Text] [Related]
7. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study.
Berth-Jones J; Damstra RJ; Golsch S; Livden JK; Van Hooteghem O; Allegra F; Parker CA;
BMJ; 2003 Jun; 326(7403):1367. PubMed ID: 12816824
[TBL] [Abstract][Full Text] [Related]
8. Topical fluticasone propionate lotion does not cause HPA axis suppression.
Hebert AA; Friedlander SF; Allen DB
J Pediatr; 2006 Sep; 149(3):378-82. PubMed ID: 16939752
[TBL] [Abstract][Full Text] [Related]
9. Hydrocortisone butyrate 0.1% lotion in the treatment of atopic dermatitis in pediatric subjects.
Matheson R; Kempers S; Breneman D; Draelos Z; Johnson CE; Loss R; Hogan DJ; Schoenfeld R; Checketts S; Kircik L; Fivenson D; Hebert AA; Williams J; Hamlin R; Groisser D; Piacquadio D
J Drugs Dermatol; 2008 Mar; 7(3):266-71. PubMed ID: 18380208
[TBL] [Abstract][Full Text] [Related]
10. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen.
Fokkens WJ; Jogi R; Reinartz S; Sidorenko I; Sitkauskiene B; van Oene C; Faris MA; Ellsworth A; Caldwell MF
Allergy; 2007 Sep; 62(9):1078-84. PubMed ID: 17686111
[TBL] [Abstract][Full Text] [Related]
11. Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream.
Breneman D; Fleischer AB; Kaplan D; Lebwohl M; Miller B; Pariser D; Rist T; Swinyer L; Liu Y; Foley V
J Drugs Dermatol; 2005; 4(3):330-6. PubMed ID: 15898289
[TBL] [Abstract][Full Text] [Related]
12. Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial.
Spergel JM; Boguniewicz M; Paller AS; Hebert AA; Gallagher PR; McCormick C; Parneix-Spake A; Hultsch T
Br J Dermatol; 2007 Aug; 157(2):378-81. PubMed ID: 17573885
[TBL] [Abstract][Full Text] [Related]
13. Topical fluticasone for infants from 3 months of age.
Prescrire Int; 2012 Jul; 21(129):179. PubMed ID: 22852282
[No Abstract] [Full Text] [Related]
14. Safety and efficacy of fluticasone furoate in pediatric patients with perennial allergic rhinitis.
Máspero JF; Rosenblut A; Finn A; Lim J; Wu W; Philpot E
Otolaryngol Head Neck Surg; 2008 Jan; 138(1):30-7. PubMed ID: 18164990
[TBL] [Abstract][Full Text] [Related]
15. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients.
Hanifin J; Gupta AK; Rajagopalan R
Br J Dermatol; 2002 Sep; 147(3):528-37. PubMed ID: 12207596
[TBL] [Abstract][Full Text] [Related]
16. Topical fluticasone propionate: intervention and maintenance treatment options of atopic dermatitis based on a high therapeutic index.
Korting HC; Schöllmann C
J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):133-40. PubMed ID: 21977914
[TBL] [Abstract][Full Text] [Related]
17. A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis.
Bissonnette R; Maari C; Provost N; Bolduc C; Nigen S; Rougier A; Seite S
J Cosmet Dermatol; 2010 Mar; 9(1):16-21. PubMed ID: 20367668
[TBL] [Abstract][Full Text] [Related]
18. Fluticasone propionate 0.05% cream once daily versus clobetasone butyrate 0.05% cream twice daily in children with atopic dermatitis.
Wolkerstorfer A; Strobos MA; Glazenburg EJ; Mulder PG; Oranje AP
J Am Acad Dermatol; 1998 Aug; 39(2 Pt 1):226-31. PubMed ID: 9704834
[TBL] [Abstract][Full Text] [Related]
19. Acute and maintenance treatment of atopic dermatitis in children - two comparative studies with fluticasone propionate (0.05%) cream.
Kirkup ME; Birchall NM; Weinberg EG; Helm K; Kennedy CT
J Dermatolog Treat; 2003 Sep; 14(3):141-8. PubMed ID: 14522623
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of fluticasone propionate on lung function and symptoms in wheezy infants.
Hofhuis W; van der Wiel EC; Nieuwhof EM; Hop WC; Affourtit MJ; Smit FJ; Vaessen-Verberne AA; Versteegh FG; de Jongste JC; Merkus PJ;
Am J Respir Crit Care Med; 2005 Feb; 171(4):328-33. PubMed ID: 15531753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
